Acarix Wins UAE Approval for AI-Powered CADScor System
United Arab Emirates, August 10, 2026 Acarix AB has announced that its CADScorĀ® System, an artificial intelligence-enabled point-of-care diagnostic...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
United Arab Emirates, August 10, 2026 Acarix AB has announced that its CADScorĀ® System, an artificial intelligence-enabled point-of-care diagnostic...
SAN FRANCISCO, USA and SUZHOU, China, August 9, 2026 Innovent Biologics and Daiichi Sankyo have entered into an exclusive...
PROVIDENCE, R.I., July 31, 2026 Nabsys 2.0, LLC has entered into a multi-year research collaboration with Indiana University School...
HOUSTON, July 31, 2026 Moleculin Biotech, Inc. announced updated positive preliminary blinded interim results from Part A of its...
MARLBOROUGH, Mass., July 30, 2026 Sumitomo Pharma America announced that the U.S. Food and Drug Administration (FDA) has granted...
WALTHAM, Mass., July 29, 2026 TScan Therapeutics announced that the first patient has been dosed with TSC-101 in the...
CAMBRIDGE, Mass., July 28, 2026 Cullinan Therapeutics announced positive feedback from the U.S. Food and Drug Administration (FDA) following...
PARIS, July 10, 2026 AB Science announced a major strategic update to its clinical development pipeline, confirming that it...
HOUSTON, July 6, 2026 Moleculin Biotech announced that Chairman and Chief Executive Officer Walter Klemp discussed encouraging preliminary results...
MENLO PARK, Calif., June 30, 2026 Orca Bio announced that the U.S. Food and Drug Administration (FDA) has approved...
